fda semaglutide lawsuit sued over 'reckless and arbitrary' decision Wegovy® Lawsuit | July 2026

FDA guidance is direct on this point: don't use an injectable GLP-1 product that arrives warm or with inadequate refrigeration, since that can affect the medication's quality

On Wednesday, the Food and Drug Administration issued a warning, calling compounded GLP-1 medications "risky for patients." "FDA is aware that some patients and health care professionals may look to unapproved versions of GLP-1 (glucagon-like peptide-1 (GLP-1) receptor agonists) drugs, including semaglutide and tirzepatide, as an option for weight loss," the FDA said

The peptide achieves 60% reduction in ROS levels in WI-38 cells pretreated with 10 nM-10 M GHK-Cu then exposed to 150 M hydrogen peroxide

acknowledges support from the Ovarian Cancer Research Alliance (MIG-2023-2-1018) and the HERA Foundation

If you experience heartburn while taking semaglutide, several evidence-based strategies can help manage symptoms without necessarily discontinuing the medication